David M. Markovitz - Toxicology

Author Information

David M. Markovitz is a distinguished researcher affiliated with the Division of Infectious Diseases, Department of Internal Medicine at the University of Michigan, Ann Arbor, MI, USA. His extensive research focuses primarily on infectious diseases, with significant work in virology and immunology.

Research Contributions

David M. Markovitz has made substantial contributions to the field of virology and immunology. His research spans various aspects of viral infections, including the development of antiviral therapies and the understanding of immune responses to viruses. Noteworthy among his recent work is the exploration of lectins as antiviral agents against SARS-CoV-2 and other coronaviruses, as well as the investigation of DEK, a nuclear protein, in hematopoietic stem/progenitor cells. His studies on CAR-NK cells for the treatment of SARS-CoV-2 infection further highlight his contributions to developing innovative therapeutic strategies.

Aliases

David M. Markovitz is also known by several aliases in the academic community, including David M Markovitz, D M Markovitz, D Markovitz, and D. M. Markovitz.

Publication and Citation Metrics

Metric	Value
Total Citation Count	8144
H-Index	48
Total Paper Count	143

Publications:

DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling.

DOI: 10.1002/JLB.3AB1120-740R

Year: 2022

Response to Berry et al’s “Cutaneous small-vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination”

DOI: 10.1016/j.jdcr.2021.08.041

Year: 2022

H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice

DOI: 10.1038/s41598-022-05580-6

Year: 2022

The Use of Lectins as Tools to Combat SARS-CoV-2.

DOI: 10.2174/1381612827666210830094743

Year: 2021

A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo

DOI: 10.21203/RS.3.RS-516695/V1

Year: 2021

Targeted disruption of pi–pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity

DOI: 10.1038/s41598-020-80577-7

Year: 2021

Extracellular DEK Treatment Mimics Hypoxic Blockade of Extra Physiologic Oxygen Stress in Human and Mouse Hematopoietic Cells

DOI: 10.1182/blood-2021-151171

Year: 2021

Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection

DOI: 10.3389/fimmu.2021.763460

Year: 2021

CAR-NK Cells Targeting Sars-Cov-2 Glycosites As COVID-19 Treatment

DOI: 10.1182/blood-2021-146865

Year: 2021

The role of the histone H3 variant CENPA in prostate cancer

DOI: 10.1074/jbc.RA119.010080

Year: 2020